These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 7762422

  • 1. Study on the binding of lactotransferrin (lactoferrin) to human PHA-activated lymphocytes and non-activated platelets. Localisation and description of the receptor-binding site.
    Mazurier J, Legrand D, Leveugle B, Rochard E, Montreuil J, Spik G.
    Adv Exp Med Biol; 1994; 357():111-9. PubMed ID: 7762422
    [Abstract] [Full Text] [Related]

  • 2. Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin.
    Legrand D, Mazurier J, Elass A, Rochard E, Vergoten G, Maes P, Montreuil J, Spik G.
    Biochemistry; 1992 Sep 29; 31(38):9243-51. PubMed ID: 1327110
    [Abstract] [Full Text] [Related]

  • 3. Lactotransferrin binding to its platelet receptor inhibits platelet aggregation.
    Leveugle B, Mazurier J, Legrand D, Mazurier C, Montreuil J, Spik G.
    Eur J Biochem; 1993 May 01; 213(3):1205-11. PubMed ID: 8389297
    [Abstract] [Full Text] [Related]

  • 4. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E, Lévy-Toledano S, Rendu F, Hermant L, Lu H, Fiat AM, Jollès P, Caen J.
    Eur J Biochem; 1990 Nov 26; 194(1):43-9. PubMed ID: 2174781
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the specific binding of human lactotransferrin to human peripheral-blood phytohaemagglutinin-stimulated lymphocytes by fluorescein labelling and location of the binding site.
    Legrand D, Mazurier J, Maes P, Rochard E, Montreuil J, Spik G.
    Biochem J; 1991 Jun 15; 276 ( Pt 3)(Pt 3):733-8. PubMed ID: 1648350
    [Abstract] [Full Text] [Related]

  • 6. KRDS--a tetrapeptide derived from lactotransferrin--inhibits binding of monoclonal antibody against glycoprotein IIb-IIIa on ADP-stimulated platelets and megakaryocytes.
    Raha S, Dosquet C, Abgrall JF, Jolles P, Fiat AM, Caen JP.
    Blood; 1988 Jul 15; 72(1):172-8. PubMed ID: 3291978
    [Abstract] [Full Text] [Related]

  • 7. The N-terminal domain I of human lactotransferrin binds specifically to phytohemagglutinin-stimulated peripheral blood human lymphocyte receptors.
    Rochard E, Legrand D, Mazurier J, Montreuil J, Spik G.
    FEBS Lett; 1989 Sep 11; 255(1):201-4. PubMed ID: 2551729
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition effects of KRDS, a peptide derived from lactotransferrin, on platelet function and arterial thrombus formation in dogs.
    Wu G, Ruan C, Drouet L, Caen J.
    Haemostasis; 1992 Sep 11; 22(1):1-6. PubMed ID: 1381697
    [Abstract] [Full Text] [Related]

  • 10. Characterization of two kinds of lactotransferrin (lactoferrin) receptors on different target cells.
    Spik G, Legrand D, Leveugle B, Mazurier J, Mikogami T, Montreuil J, Pierce A, Rochard E.
    Adv Exp Med Biol; 1994 Sep 11; 357():13-9. PubMed ID: 7762424
    [Abstract] [Full Text] [Related]

  • 11. Isolation and characterization of sheep lactoferrin, an inhibitor of platelet aggregation and comparison with human lactoferrin.
    Qian ZY, Jollès P, Migliore-Samour D, Fiat AM.
    Biochim Biophys Acta; 1995 Jan 18; 1243(1):25-32. PubMed ID: 7827104
    [Abstract] [Full Text] [Related]

  • 12. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.
    Elass-Rochard E, Roseanu A, Legrand D, Trif M, Salmon V, Motas C, Montreuil J, Spik G.
    Biochem J; 1995 Dec 15; 312 ( Pt 3)(Pt 3):839-45. PubMed ID: 8554529
    [Abstract] [Full Text] [Related]

  • 13. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S, Lu X, Kakkar VV, Authi KS.
    Biochem J; 1995 Nov 15; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDS.
    Drouet L, Bal dit Sollier C, Cisse M, Pignaud G, Mazoyer E, Fiat AM, Jolles P, Caen JP.
    Nouv Rev Fr Hematol (1978); 1990 Nov 15; 32(1):59-62. PubMed ID: 2349083
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM, Houghten RA, Russell SR, Zimmerman TS.
    Proc Natl Acad Sci U S A; 1986 Aug 15; 83(15):5708-12. PubMed ID: 3016716
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Haemin affects platelet aggregation and lymphocyte mitogenicity in whole blood incubations.
    Malik Z, Creter D, Cohen A, Djaldetti M.
    Cytobios; 1983 Aug 15; 38(149):33-8. PubMed ID: 6313299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.